Interestingly, we have previously reported CD2 and COL5A2 in a single gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors [14], suggesting that underlying biological mechanisms behind immune TME formation can be at least in part shared among tumors in different organs. This evidence concerns the gene COL5A2 and ovarian neoplasm.